Mission Street’s Post

Doxy and tige and erava – oh my!  How do you differentiate their spectra of activity?  🤨 With this handy infographic!  Developed by SIDP members and sponsored by Innoviva Specialty Therapeutics

Various Tetracyclines (Tetracycline, Doxycycline, Minocycline, Tigecycline, Eravacycline and Omadacycline) and their spectrum of activity

Unlock the potential of light scattering techniques in quality control and development processes of mRNA-LNP therapeutics. Join our webinar tomorrow, May 7th, to gain an edge in your research.

🎙In our newest #RunningThroughWalls episode, Nimish Shah speaks with Mirador Therapeutics Chairman and CEO Mark McKenna about the beginning of Mirador, what he learned from his time at Prometheus, what he values in a team and more. Listen here: https://vnrk.co/3KxobCR 

🔬 Co-founder and CEO of YouthBio Therapeutics Inc., Yuri Deigin, shares the path that led him to establish a company focused on longevity research. 📽️ Watch his episode of Founders here. ⏩ https://bit.ly/FoundersE21

We're at #PEGSummit this week! Our scientists Shelby Knoche and Michael J McGuire will be presenting on SRI's targeted drug delivery technologies. If you're not at the conference, you can learn more about our platform, called FOX Three, for cell-selective intracellular delivery of macromolecular therapeutics here: https://lnkd.in/g65HJvt4 #drugdelivery #precisionmedicine

#TIDESEurope kicked off today! Stop by the Codexis, Inc. booth (# 709) to learn more about how we can accelerate your #RNA therapeutics research. In addition to three presentations showcasing data from our enzymatic #siRNA manufacturing solutions, our team will be on the ground to answer your questions and share how you can incorporate enzymatic synthesis into your processes. #RNAitherapeutics #CDXS #enzymes #enzymaticsynthesis

Explore the results of the ORIGIN Phase 2b study and open-label extension in this video abstract and download the #visualabstract, supported by Vera Therapeutics, Inc. https://ow.ly/lnbK50Us17E

In the October edition of LifeLines, we highlighted member companies driving the latest advancements in AI and drug discovery, including BigHat Biosciences, Genesis Therapeutics, insitro and more. Read the story here: https://bit.ly/40y9yIH

Achieving Next-Generation mRNA-LNP Therapeutics Delivery https://lnkd.in/e_H8yJEJ Three LNP experts (Dr. Kate Zhang, Professor Ben Muir, and Dr. Sumit Luthra) parse out the current opportunities and unknowns facing the development of next-generation LNPs.